Gender-related differences in the management of hypertension by cardiologists: The PARITE study

Archives of Cardiovascular Diseases

Volumn 105, Issue 5, 2012, Pages 271-280

  Mounier Vehier, Claire ^a   Simon, Tabassome ^b,c   Guedj Meynier, Dominique ^d   Ferrini, Marc ^d   Ghannad, Emmanuel ^e   Hubermann, Jean Pierre ^d   Jullien, Gérard ^d   Poncelet, Pascal ^e   Achouba, Assya ^f   Quéré, Stéphane ^f   Guenoun, Maxime ^d  

^a UNIV LILLE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d Collège National des Cardiologues Français ^*  (France)

^e Polyclinique de Hénin Beaumont ^*  (France)

^f NOVARTIS PHARMA K K   (Japan)

Author keywords

Cardiovascular disease; Gender; Global cardiovascular risk; Hypertension; Women

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOLOGIST; CARDIOLOGY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONSULTATION; CROSS-SECTIONAL STUDY; ESSENTIAL HYPERTENSION; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OFFICE WORKER; SEX DIFFERENCE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOLOGY; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OFFICE VISITS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84862852173     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2012.03.003     Document Type: Article

References (20)

1. Stramba-Badiale M, Fox KM, Priori SG, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27:994-1005.
2. Rosengren A, Wallentin L, A KG, et al. Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J 2004;25:663-70.
3. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-60.
4. Gall SL, Donnan G, Dewey HM, et al. Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology 2010;74:975-81.
5. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997;126:761-7.
6. Fricker J. Women's heart health: the focus of this issue. Eur Heart J 2011;32:1301-10.
7. Maas AH, van der Schouw YT, Regitz-Zagrosek V, et al. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J 2011;32:1362-8.
8. Samson S, Ricordeau P, Pepin S, et al. Hypertension artérielle et facteurs de risque associés : évolutions des traitements entre 2000 et 2006. Caisse nationale d'assurance maladie des travailleurs salariés : points de repères No 10 2007:1-8.
9. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
10. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003;21: 1055-76.
11. Caussé C, Nazal EM, Leutenegger E, et al. Influence des facteurs de risqué cardiovasculaire et de l'atteinte des organes cibles sur le niveau de la pression pulse chez l'hypertendu traité. Arch Mal Coeur Vaiss 2004;P8:27.
12. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007;25:1751-62.
13. Haute Autorité de santé. Prise en charge des patients adultes atteints d'hypertension artérielle essentielle -actualisation 2005. Service des recommandations professionnelles: available at: http://www.has-sante.fr/portail/upload/ docs/application/pdf/2011-09/hta 05 - recommandations. pdf.
14. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007;115:1481-501.
15. Godet-Thobie H, Vernay M, Noukpoape A, et al. Niveau tensionnel moyen et prévalence de l'hypertension artérielle chez les adultes de 18 à 74 ans, ENNS 2006-2007. Bull Epid Hebd 2008;49-50:478-83.
16. Wagner A, Sadoun A, Dallongeville J, et al. High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens 2011;29:43-50.
17. Boggia J, Thijs L, Hansen TW, et al. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension 2011;57:397-405.
18. Mounier-Vehier C, Amah G, Covillard J, et al. Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study. Evaluation and stratification of cardiovascular risk based on the 2000 ANAES recommendations in a population of hypertensive patients. Arch Mal Coeur Vaiss 2002;95:667-72.
19. Simon T, Mary-Krause M, Cambou JP, et al. Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women: results from the French nation-wide USIC registries. Eur Heart J 2006;27:1282-8.
20. Simon T, Mary-Krause M, Funck-Brentano C, et al. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001;103:375-80.